Novo Nordisk may be reorganizing its early-stage R&D capabilities, but the Danish pharma’s chief scientific officer has insisted that the changes aren’t primarily about laying off staff.

Lilly beats Novo Nordisk to launch weight-loss drug in India Mounjaro's 5 mg vial priced at around $50, 2.5 mg at about $40 Drug's pricing may limit accessibility in India, analyst says Novo's ...

Since the “Hey Siri” voice activation can’t be customized to load up any other app, you’re going to need to find another way to fire-up ChatGPT, and the solution lies in the Action button.

‘K1’ is the talk of the town now. The button on Lewis Hamilton’s steering wheel became a subject of intrigue at last weekend’s Australian GP. Throughout the race, his race engineer, Riccardo Adami, ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

Bagsværd, Denmark-based Novo Nordisk is a global healthcare company and a prominent player in the diabetes market with a full portfolio of glucagon-like peptide 1 (GLP-1) receptor agonists ...

Novo Nordisk shares gained Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart ...

For Novo Nordisk A/S investors (NVO), things couldn't have gotten to a worse start this week. Just when the market was preparing for a bottom, as NVO has been consolidating constructively over the ...

Stock availability and pricing subject to change depending on retailer or outlet. You can toggle all your mods on/off with a single button press in patch 8 If you’re the kind of person who enjoys ...

Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after long-time skeptic Kepler Cheuvreux finally upgraded its ...